Wednesday Nov 11 | BNET
Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson
Despite best efforts to build a diversified health care business, the fortunes of Johnson & Johnson remain tethered to prescription drug sales, which comprise almost 40 percent of total revenue.
Should I move to a different state?
Should I move to a different state? 10/16/09 Hopeful Topics: Environment I recently spent a year in Colorado.
Larry Birkhead: Anna Nicole Suffered Seizures, Popped Pills on Daily Basis
Today's star attraction in the Anna Nicole Smith drug-plying case/circus : none other than her baby daddy Larry Birkhead .
FDA approves generic epilepsy treatment
PITTSBURGH Generic drug maker Mylan has received the Food and Drug Administrationa s approval for its version of a drug used to treat epilepsy.
Johnson & Johnson needs a pep pill. For the second quarter in a row, revenue from medical devices and diagnostics came in higher than the revenue supplied by its pharmaceutical segment.
J&J reports moderately higher earnings
Johnson & Johnson early Tuesday reported moderately higher third-quarter earnings, but its sales performance was tempered by declining sales of two of its top-selling prescription drugs, Topamax and Risperdal, due to increased generic competition.
J&J faces pain from generic rivals
Healthcare products giant Johnson & Johnson is expected to report moderately lower third-quarter earnings Tuesday, due in part to the loss of patent protection on such top-grossing drugs as Risperdal and Topamax.
Four percent annual growth for chronic pain drug market
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Why Vivus's Qnexa Might Not Avoid the Obesity Drug Graveyard
Many have tried. None have succeeded. And now Vivus - a young Arthur of Pharmalot, if you will - believes it can pull the sword from the stone.
Qnexa, an experimental obesity drug, helped people lose an average of nearly 15% of their body weight by combining an older weight-loss drug with an epilepsy drug, corporate researchers said on Wednesday.
Vivus Ahead in Race For New Weight Loss Drug
Three drug companies are racing to get approval from the US Food and Drug Administration to sell the next weight loss pill.
Allergan's Botox Reduces Migraine Headache Days
Botox, the popular wrinkle-smoother sold by Allergan Inc, significantly reduced the number of headache days for adults suffering from chronic migraines, according to two late-stage trials.
Vivus's Experimental Diet Treatment Meets Goals in Weight-Loss Research
Vivus Inc . said its experimental weight-loss drug Qnexa helped patients lose enough weight in studies to allow the biotechnology company to seek U.S. approval to sell the treatment this year.
Unless your healthcare provier tells you otherwse, drink when vicodin withdrawl and infant massage, you are thirtsy.. Avoid other over-te-counter and topamax weight presrciption prdoucts that buy norco medication 35560, cotain aspiin.
FDA pregnany caetgory C. This mediction may be harmfl norvasc 5mg purchase, to an unborn baby.
Hyperproteinemia secondary to coumadin
Talk xanax adverse side effects, to your doctor about any side effect that effects of tylenol pm, seems unusaul or that is especailly botherosme.
Medication Update First generic topamax to prevent seizures The FDA has approved the first generic version of topiramate tablets to prevent seizures.
Five Small-Cap Weight Loss Trades
Below are five small/micro-cap companies from the BioMedReports.com FDA Calendar with late-stage drugs or medical devices in development for prescription weight loss.
The health-care products company's second-quarter results suggest better times are ahead.
Dangers of generic brand prescriptions
When you buy generic prescription medicines, you may be doing more than just saving money.
Also on Topix